Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluovouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 316-322

  Harper Wynne, C ^a   English, J ^a   Meyer, L ^b   Bower, M ^a   Archer, C ^a   Sinnett, H D ^c   Lowdell, C ^c   Coombes, R C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; Metastases; Methotrexate; Mitoxantrone

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; MITOXANTRONE;

ADULT; AGED; ALOPECIA; ARTICLE; BREAST CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; STATISTICAL ANALYSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 0032857020     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6990694     Document Type: Article

References (23)

1. Aisner J, Weinberg V, Perloff M, et al (1987) Chemotherapy versus chemoimmunotherapy (CAFV CAFVP v CMF IMER) for metastatic carcinoma of the breast. A CALGB study, J Clin Oncol 5: 1523-1533
2. Bull JM, Tormey DC, Shou-Hua L, et al (1978) A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy, Cancer 41: 1649-1657
3. Canellos GP, De Vita VT, Gold GL, et al (1976) Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Int Med 84: 389-392
4. Clavel M and Catimel G (1993) Breast cancer: chemotherapy in the treatment of advanced disease. Eur J Cancer 29A 4: 598-604
5. Cummings FT, Gelman R and Horton J (1995) Comparison of CAF versus CMFP in metastatic breast cancer: Analysis of prognostic factors, J Clin Oncol 3; 932-940
6. De-Hacs JC, van-Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients; structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62: 1034-1038
7. EORTC: A practical guide to EORTC Studies, 1996 February
8. Greenspan EM (1966) Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma. J Mt Sinai Hosp 33: 1-27
9. Hayward JL, Rubens RD, Carbone PP et al (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292-298
10. Honig SF (1996) Treatment of metastatic disease: hormonal therapy and chemotherapy. In: Diseases of the Breast, Harris JR, Lippman MC, Morrow M, et al (eds), pp. 669-734. Lippincott: Philadelphia
11. Jodrell DI, Smith IE, Mansi JL et al (1991) A randomised comparative trial of mitoxantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer. Br J Cancer 63: 794-798
12. Maguire P and Selby P (1989) Assessing quality of life in cancer patients. Br J Cancer 60: 437-440
13. Mouridsen H (1992) Systemic therapy of advanced disease. Drugs 44: 17-28
14. Payne SA (1992) A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med 35: 1505-1509
15. Peto R, Pike MC, Armitage P et al (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part 2 Analysis and examples. Br J Cancer 35: 1-39
16. Powles TJ, Jones AL, Judson IR et al (1991) A randomised trial comparing combination chemotherapy using mitomycin C, mitoxantrone and methotrexate (3M) with vineristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. Br J Cancer 64: 406-410
17. Smalley RV, Lefante J, Bartolucci A et al (1983) CAF v CMFVP in patients with advanced breast cancer. Breast Cancer Teat Res 3: 209-210
18. Stein RC, Bower M, Law M et al (1992) Mitoxantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: A randomised clinical trial. Eur J Cancer 28A: 1963-1965
19. Stewart DJ, Evans WK, Shepherd FA et al (1997) Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin. J Clin Oncol 15: 1897-1905
20. Tannock IF, Boyd NF, DeBoer G et al (1988) A randomised trial of two dose levels of cyclophosphamide, methotrexate and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6: 1377-1387
21. Tormey DC, Gelman R, Band PR et al (1982) Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial. Cancer 50: 1235-1244
22. World Health Organisation (1979) WHO Handbook for Reporting of Cancer Treatment .WHO: Geneva
23. Zigmond AS and Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-363